Skip to content

ARWRARROWHEAD PHARMACEUTICALS IN

CUSIP 04280A100 · common stock · Other share classes: 04280AAC4

5 tracked investors held ARROWHEAD PHARMACEUTICALS IN (ARWR) at the end of Q3 2026, worth $175.8M in total. The largest holder was Julian Baker, with 0.5% of its portfolio. Ron Baron opened a new position this quarter.

Holders · Q3 2026
5
New holders
1
Value held
$175.8M
Quarter-end price (est.)
$65.45

Investors holding ARWR · Q3 2026

InvestorWeightSharesValueChange
Julian Baker
Baker Bros. Advisors LP
0.53%1,709,053$111.9MREDUCE-14.2%
Ken Fisher
Fisher Asset Management, LLC
0.02%893,700$58.5MREDUCE-6.7%
Adar1 Capital Management
ADAR1 Capital Management, LLC
0.19%69,200$4.5MREDUCE-0.9%
Joel Greenblatt
Gotham Asset Management, LLC
0.00%9,620$629.6KADD+43.7%
Ron Baron
BAMCO Inc. (Baron Capital)
0.00%5,000$327.3KNEW

Sold out this quarter

InvestorPrior weightPrior sharesPrior valueChange
Polen Capital Management0.00%6,612$538.9KEXIT

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026511$175.8M$65.45
Q2 2026510$247.3M$81.51
Q1 2026400$201.6M$62.70
Q4 2025400$239.1M$66.39